In 2014 , Dr. Dr. Gottlieb a medical device study that used " sham , " or dummy , procedures as Dr. Gottlieb placebo .The sham procedure , he argued , was invasive and unnecessary , especially since the product , called renal denervation , was Some of Dr. Gottlieb’s views approved in Europe Dr. Gottlieb patients’ blood pressure .But at the time Dr. Gottlieb wrote the article , Medtronic , the device ’s manufacturer , had already announced that the Dr. Gottlieb had failed , and an article a month later in The New England Journal of Medicine showed that patients who underwent renal denervation did no better than those who received a Dr. Gottlieb ."